Fig. 2
From: EXOSC5: a novel biomarker for poor prognosis in lung adenocarcinoma
EXOSC5 is a high-risk factor in LUAD (TCGA cohort). A: Univariate and multivariate OS analyses of the TCGA cohort. B: Survival comparison between the high and low EXOSC5 groups. C-D: EXOSC5 mRNA expression across N stages and stage classifications. E: Three- and five-year OS nomogram incorporating EXOSC5 expression, N stage, T stage, and stage classification. F-G: Three-year and five-year ROC curves for EXOSC5 expression, stage classification, and the risk model